ERYTHROMYCIN ETHYLSUCCINATE AND SULFISOXAZOLE ACETYL Drug Patent Profile
✉ Email this page to a colleague
When do Erythromycin Ethylsuccinate And Sulfisoxazole Acetyl patents expire, and when can generic versions of Erythromycin Ethylsuccinate And Sulfisoxazole Acetyl launch?
Erythromycin Ethylsuccinate And Sulfisoxazole Acetyl is a drug marketed by Barr and is included in one NDA.
The generic ingredient in ERYTHROMYCIN ETHYLSUCCINATE AND SULFISOXAZOLE ACETYL is erythromycin ethylsuccinate; sulfisoxazole acetyl. There are one hundred and three drug master file entries for this compound. Additional details are available on the erythromycin ethylsuccinate; sulfisoxazole acetyl profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ERYTHROMYCIN ETHYLSUCCINATE AND SULFISOXAZOLE ACETYL?
- What are the global sales for ERYTHROMYCIN ETHYLSUCCINATE AND SULFISOXAZOLE ACETYL?
- What is Average Wholesale Price for ERYTHROMYCIN ETHYLSUCCINATE AND SULFISOXAZOLE ACETYL?
Summary for ERYTHROMYCIN ETHYLSUCCINATE AND SULFISOXAZOLE ACETYL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | ERYTHROMYCIN ETHYLSUCCINATE AND SULFISOXAZOLE ACETYL at DailyMed |
US Patents and Regulatory Information for ERYTHROMYCIN ETHYLSUCCINATE AND SULFISOXAZOLE ACETYL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Barr | ERYTHROMYCIN ETHYLSUCCINATE AND SULFISOXAZOLE ACETYL | erythromycin ethylsuccinate; sulfisoxazole acetyl | GRANULE;ORAL | 062759-001 | May 20, 1988 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
